
Organization · Venture Capital
Cape Fear BioCapital
Cape Fear BioCapital is an early-stage venture capital firm based in Durham, North Carolina, focused on investing in therapeutics companies emerging from the local research ecosystem. The firm targets pre-seed to seed-stage investments, leveraging regional academic resources to foster innovation in life sciences.
Overview
What Cape Fear BioCapital does
What Cape Fear BioCapital is
Cape Fear BioCapital is an early-stage venture capital firm based in Durham, North Carolina, focused on investing in therapeutics companies emerging from the local research ecosystem. The firm targets pre-seed to seed-stage investments, leveraging regional academic resources to foster innovation in life sciences.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2024
- Approximate age
- About 2 years
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find Cape Fear BioCapital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Cape Fear BioCapital as a funder
Investment thesis
Cape Fear BioCapital invests where differentiated biology can become seed-ready therapeutics companies, focusing on pre-seed to seed stages, particularly those with clear paths to clinical development.
Focus narrative
Cape Fear BioCapital focuses on investing in early-stage therapeutics companies, particularly those rooted in North Carolina. The firm targets pre-seed to seed-stage investments in companies with validated scientific foundations and clear paths to clinical development. By emphasizing platform companies with multi-indication potential and single-asset programs, Cape Fear BioCapital aims to accelerate the clinical progress of its portfolio companies, especially those nearing Investigational New Drug (IND) filing.
Value beyond capital
Cape Fear BioCapital adds value to its portfolio companies by providing hands-on company building, operational support, and access to strategic partners. The firm focuses on helping founders secure intellectual property, complete proof-of-concept work, and attract follow-on investments, thereby accelerating the path from academic research to clinical application.
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 6
Portfolio context
Thoracic Innovations: A medical device company developing novel surgical tools for cardiothoracic surgery. (Location: Durham, NC) Ten63 Therapeutics: An AI-enabled drug discovery company leveraging its proprietary BEYOND platform to design small molecules for oncology. (Stage: Series A, Location: Durham, NC) Incyclix Bio: A clinical-stage oncology company advancing a selective CDK2 inhibitor for specific cancer types. (Stage: Series B, Location: Durham, NC) iOrganBio: A cell manufacturing platform company utilizing AI-driven predictions for the production of human cells and organoids. (Stage: Pre-Seed, Location: Durham, NC) EnFuego Therapeutics: An early-stage oncology company developing a breakthrough siRNA platform targeting difficult cancer pathways. (Stage: Pre-Seed, Location: Chapel Hill, NC) Eldec Pharmaceuticals: A peptide therapeutics company developing a modulator for chronic respiratory disease. (Stage: Pre-Seed, Location: Chapel Hill, NC)
Connected ecosystem
Continue from Cape Fear BioCapital
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Cape Fear BioCapital
Upseed classifies Cape Fear BioCapital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.